MERKEL CELL CARCINOMA
Clinical trials for MERKEL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MERKEL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for MERKEL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug BDB001 tested in patients whose tumors resisted standard immunotherapy
Disease control CompletedThis study tested an experimental drug called BDB001 in people with advanced solid tumors (like skin, lung, or kidney cancer) that had stopped responding to standard immunotherapy. The goal was to see if BDB001 could shrink tumors or slow their growth. Only one person took part, …
Matched conditions: MERKEL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Cancer patients may not need lifelong immunotherapy, study suggests
Knowledge-focused CompletedThis study looked at people with advanced solid tumors (like lung, bladder, or melanoma) who had been on immunotherapy for one year and whose disease was stable. Half stopped treatment and half continued. The goal was to see if stopping early affected how long until the cancer pr…
Matched conditions: MERKEL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Dan Zandberg • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC